On April 1st, NMQF brought together leading experts and a passionate caregiver advocate to spotlight Transthyretin Amyloid Cardiomyopathy (ATTR-CM) — a rare and often overlooked cause of heart failure impacting underserved communities.
Moderated by Chinnie Ukachukwu, MPH, with insights from Dr. Nitasha Sarswat, Dr. Jannae White, and Velma Henderson, RN, the panel discussed early detection, breakthrough treatments, and why advocacy and persistence can change lives.
Early detection saves lives. Clinical trials offer hope. Advocacy builds stronger futures.
Watch the Full Video
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
pubmed
- Subash Kafle
